Evidence map›Paper›PMID 33216833›Full record

ArticleOncotarget2020

Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model.

Robert A Kazmierczak, Bakul Dhagat-Mehta, Elke Gulden, Li Lee, Lixin Ma, Clintin P Davis-Stober, Austen A Barnett, Yves C Chabu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Robert A KazmierczakCancer Research Center, Columbia, MO, USA.
Bakul Dhagat-MehtaCancer Research Center, Columbia, MO, USA.
Elke GuldenDepartment of Immunobiology, Yale University, New Haven, CT, USA.
Li LeeDepartment of Radiology and Department of Physics and Astronomy, University of Missouri, Columbia, MO, USA.
Lixin MaDepartment of Radiology and Department of Physics and Astronomy, University of Missouri, Columbia, MO, USA.
Clintin P Davis-StoberDepartment of Psychological Sciences, Institute for Data Science & Informatics, University of Missouri, Columbia, MO, USA.
Austen A BarnettDepartment of Biology, DeSales University, Center Valley, PA, USA.
Yves C ChabuDivision of Biological Sciences, University of Missouri, Columbia, MO, USA.
University of Missouri · USCancer Research Center · USDeSales University · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional cancer chemotherapies are not fully efficacious and do not target tumors, leading to significant treatment-related morbidities. A number of genetically attenuated cancer-targeting bacteria are being developed to safely target tumors

Indexed as

cancer targetingimmunotherapyprostate cancersalmonellaTRAMP

Identifiers

PMID33216833
PMCPMC7646835
OpenAlexW3094654430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.